Tanacechol filmcoated tablets 0.05 g (Tablets) Instructions for Use
ATC Code
A05AX (Other drugs for the treatment of biliary tract diseases)
Active Substance
Tanacetum vulgare flores (State Pharmacopoeia)
Clinical-Pharmacological Group
Herbal preparation with choleretic and spasmolytic action
Pharmacotherapeutic Group
Choleretic agent of plant origin
Pharmacological Action
Anthelmintic and choleretic agent of plant origin.
The anthelmintic action of tansy flowers is due to the presence of essential oil.
The complex of biologically active substances of tansy flowers also has antimicrobial and anti-inflammatory effects, enhances bile secretion, and reduces the mucus content in bile.
Indications
Use this medication for the treatment of the following conditions as determined by a healthcare professional.
- Ascariasis and enterobiasis for its anthelmintic properties.
- As a choleretic agent within a comprehensive treatment plan for chronic non-calculous cholecystitis and hypomotor dyskinesia of the biliary tract to stimulate bile flow.
ICD codes
| ICD-10 code | Indication |
| B77 | Ascariasis |
| B80 | Enterobiasis |
| K81.1 | Chronic cholecystitis |
| K82.8 | Other specified diseases of gallbladder and cystic duct (including dyskinesia) |
| ICD-11 code | Indication |
| 1F62 | Ascariasis |
| 1F65 | Enterobiasis |
| DC12.1 | Chronic cholecystitis |
| DC1Z | Diseases of gallbladder and biliary tract, unspecified |
| DD94 | Functional disorder of the gallbladder |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the tablets orally. The specific dosage regimen must be individually determined by a physician based on the indication being treated and the patient’s clinical presentation.
For anthelmintic use against ascariasis and enterobiasis, the dosage and duration will differ from that used for choleretic purposes in biliary tract disorders. Adhere strictly to the prescribed schedule.
Adverse Reactions
During treatment, monitor for potential adverse effects. Allergic reactions are possible and may require discontinuation.
When administered in high doses, gastrointestinal disturbances such as nausea, vomiting, and diarrhea may occur. Report any persistent or severe reactions to a healthcare provider immediately.
Contraindications
Do not administer this medication under the following conditions due to the risk of serious adverse effects.
- Hypersensitivity to the active substance (Tanacetum vulgare flores) or any other component of the preparation.
- Patients with cholelithiasis (gallstones) due to the risk of triggering biliary colic.
- Pregnancy and lactation (breastfeeding) are absolute contraindications.
- Use in children and adolescents under 18 years of age is prohibited.
Drug Interactions
Formal drug interaction studies have not been conducted with this herbal preparation. Exercise caution when co-administering with other medications.
Due to its choleretic effect, monitor for potential interactions with other drugs affecting hepatobiliary secretion. Consult a healthcare professional before combining with any other prescription or non-prescription medicines.
Overdose
Symptoms of overdose are an extension of the adverse reaction profile, primarily severe gastrointestinal disturbances including vomiting and diarrhea.
In case of suspected overdose, discontinue the medication immediately and initiate symptomatic and supportive care. There is no specific antidote; seek immediate medical attention.
Use in Pregnancy and Lactation
Use is contraindicated during pregnancy and lactation (breastfeeding).
Use in Hepatic Impairment
Use is contraindicated in patients with cholelithiasis.
Pediatric Use
Use is contraindicated in children and adolescents under 18 years of age.
Special Precautions
The prepared infusion can be stored in a cool place for no more than 2 days.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Coated tablets, 50 mg: 30 pcs.
Marketing Authorization Holder
Dalkhimpharm, JSC (Russia)
Dosage Form
 |
Tanacechol filmcoated tablets 0.05 g | Coated tablets, 50 mg: 30 pcs. |
Dosage Form, Packaging, and Composition
| Coated tablets | 1 tab. |
| Dry extract of common tansy flowers | 50 mg |
30 pcs. – dark glass jars.
30 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
Coated tablets, 50 mg: 30 pcs.
Marketing Authorization Holder
PhytoPharm-NN NZLP, FSUE (Russia)
Dosage Form
|
Tanacechol filmcoated tablets 0.05 g | Coated tablets, 50 mg: 30 pcs. |
Dosage Form, Packaging, and Composition
| Coated tablets | 1 tab. |
| Dry extract of common tansy flowers | 50 mg |
30 pcs. – dark glass jars.
30 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
Coated tablets, 50 mg: 30 pcs.
Marketing Authorization Holder
Shchelkovsky Vitamin Plant, JSC (Russia)
Dosage Form
|
Tanacechol filmcoated tablets 0.05 g | Coated tablets, 50 mg: 30 pcs. |
Dosage Form, Packaging, and Composition
| Coated tablets | 1 tab. |
| Dry extract of common tansy flowers | 50 mg |
30 pcs. – dark glass jars.
30 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
![Tanacechol filmcoated tablets 0.05 g [Tablets] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Tanacechol filmcoated tablets 0.05 g [Tablets] 2")